March 12, 2018

Overexpression of SlC7A11: A Novel Oncogene and an Indicator of Unfavorable Prognosis for Liver Carcinoma

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

SLC7A11 overexpression might be a novel biomarker and a potential unfavorable prognostic factor as well as a potential therapeutic target for liver carcinoma.

Preguntar a la IA

Me gusta

Guardar

Cite This Study

Zhang et al. (Mon,) studied this question.

synapsesocial.com/papers/69dc3651d74bf23813c0fb54 https://doi.org/https://doi.org/10.2217/fon-2017-0540

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Excitotoxic SLC7A11 Expression Is a Marker of Poor Glioblastoma Survival and a Potential Therapeutic Target2015 · 11 citations
2Cadmium, Organ Toxicity and Therapeutic Approaches: A Review on Brain, Kidney and Testis Damage2017 · 163 citations
3Cadmium Exposure and Cancer Mortality in a Prospective Cohort: The Strong Heart Study2014 · 185 citations
4CD147 as a Novel Prognostic Biomarker for Hepatocellular Carcinoma: A Meta-Analysis2017 · 31 citations
5CD1472014 · 84 citations

Preguntar a la IA

Me gusta

Guardar